Dr McAndrew on a Subgroup Analysis of NATALEE in HR+/HER2– Early Breast Cancer
Nicholas P. McAndrew, MD, MSCE, hematologist-oncologist, assistant clinical professor, medicine, University of California, Los Angeles (UCLA), David Geffen School of Medicine, UCLA Medical Center, discusses a subgroup analysis of the phase 3 NATALEE trial …